close
close

scPharmaceuticals Announces Non-Dilutive Financing Totaling $125 Million with Perceptive Advisors Page 1

scPharmaceuticals Announces Non-Dilutive Financing Totaling 5 Million with Perceptive Advisors Page 1

scPharmaceuticals received $75 million through a combination of debt and royalty financing at closing, with access to an additional $50 million

The term loan refinances the principal amount of the existing debt, reduces the coupon, extends the interest-only period by four additional years and reduces the minimum cash requirement to $5 million